Institut de Neurociències
Department de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona
Carlos A. Saura obtained his Ph.D. in Chemistry/Biochemistry and Molecular Biology from the University of Barcelona (Spain). Dr. C. Saura performed postdoctoral training at Prof. G. Thinakaran´s lab at the Department of Pathology-Johns Hopkins University School of Medicine and Department of Neurobiology -University of Chicago. Dr. Saura investigated the biology of autosomal-dominant familial Alzheimer’s disease-linked mutations. Dr. Saura was then appointed Instructor Professor at the Center for Neurologic Diseases, Brigham and Women’s Hospital/Harvard Medical School (Boston). Under the mentoring of Prof. J. Shen, Dr. Saura investigated the cellular and molecular mechanisms underlying memory and neurodegeneration in novel transgenic and knockout mouse models of Alzheimer’s disease. In 2004, he was appointed Ramón y Cajal Research Professor at the Universitat Autònoma de Barcelona (Spain). Dr. C. Saura is currently Associate Professor at the Department of Biochemistry and Molecular Biology and Institut de Neurociències of UAB, and member of the Spanish National Neurodegeneration network CIBERNED. Dr. Saura has published more than 60 peer-reviewed articles on molecular and cellular mechanisms of brain physiology and pathology. He has leaded several national and international research projects and is an active collaborator of several national and international funding agencies and scientific journals.

Moderator of 1 Session

Session Type
SYMPOSIUM
Date
Fri, 18.03.2022
Session Time
02:45 PM - 04:45 PM
Room
ONSITE: 114

Presenter of 1 Presentation

LOSS OF PRESENILIN FUNCTION CAUSES TAU PHOSPHORYLATION AND AGGREGATION IN MICE

Session Type
SYMPOSIUM
Date
Fri, 18.03.2022
Session Time
02:45 PM - 04:45 PM
Room
ONSITE: 114
Lecture Time
03:30 PM - 03:45 PM

Abstract

Aims

Mutations in the presenilin (PS/PSEN) genes encoding the catalytic components of γ-secretase accelerate amyloid-β (Aβ) and tau pathologies in familial Alzheimer’s disease (AD). The mechanisms by which PSEN mutations affect Aβ are well defined, but the precise role PS/γ-secretase on tau pathology in neurodegeneration independently of Aβ is largely unclear. Here, we aimed to define the cellular mechanisms by which PS regulates tau pathology during neurodegeneration.

Methods

We performed molecular, pathological and behavioral analyses in novel mutant Tau transgenic mice lacking presenilin-1 (PS1) or both PS genes in glutamatergic neurons.

Results

Neuronal PS deficiency in conditional knockout (cKO) mice results in age-dependent brain atrophy, inflammatory responses and accumulation of pathological tau in neurons and glial cells associated with altered tau kinases. Interestingly, genetic inactivation of PS1 or both PS genes in a mouse model of frontotemporal dementia expressing mutant human tau exacerbates memory deficits by accelerating phosphorylation and aggregation of tau in excitatory neurons of vulnerable AD brain regions. Remarkably, neurofilament (NF) light chain levels are abnormally accumulated in Tau mice lacking PS. Synchroton infrared microspectroscopy revealed aggregated and oligomeric β-sheet structures in amyloid plaque-free PS-deficient Tau mice. Hippocampal-dependent memory deficits are associated with synaptic tau accumulation and reduction of pre- and post-synaptic proteins in PS-deficient Tau mice.

Conclusions

Partial loss of PS/γ-secretase in neurons causes temporal- and spatial-dependent tau aggregation associated with memory and synaptic deficits and neurodegeneration. Our findings show that tau phosphorylation and aggregation are key pathological processes that may underlie neurodegeneration caused by familial AD-linked PS mutations.

Hide